Molecular Templates, Inc. (MTEM): Price and Financial Metrics
MTEM Price/Volume Stats
| Current price | $0.00 | 52-week high | $1.78 |
| Prev. close | $0.00 | 52-week low | $0.00 |
| Day low | $0.00 | Volume | 2,100 |
| Day high | $0.00 | Avg. volume | 57,494 |
| 50-day MA | $0.00 | Dividend yield | N/A |
| 200-day MA | $0.73 | Market Cap | 0.66K |
MTEM Stock Price Chart Interactive Chart >
Molecular Templates, Inc. (MTEM) Company Bio
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of immunotoxins called engineered toxin bodies for the treatment of cancer and other serious diseases. It develops MT-3724, a lead drug candidate that is in a Phase 1 clinical trial in heavily pre-treated non-Hodgkin's lymphoma patients; MT-4019, a preclinical drug candidate targeting CD38; and evofosfamide, an investigational hypoxia-activated prodrug of a bis-alkylating agent that is preferentially activated under severe hypoxic tumor conditions, a feature of many solid tumors. The company is based in Austin, Texas.
MTEM Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
MTEM Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | 0.00% |
| 1-year | 0.00% |
| 3-year | 0.00% |
| 5-year | 0.00% |
| YTD | 0.00% |
| 2024 | -98.93% |
| 2023 | -24.19% |
| 2022 | -91.63% |
| 2021 | -58.25% |
| 2020 | -32.86% |